Fwd: Re: [rda-covid19-clinical] Clinical Sub-Group Meeting 6 May 1.00 pm UTC

Dear RDA COVID-19 Clinical Subgroup members, Dear new colleagues with
Dear RDA COVID-19 Clinical Subgroup members, Dear new colleagues with
competences in "imaging"
>
> Thanks to all the members who attended our RDA COVID-19 Clinical
> Subgroup weekly meeting last week and contributed to the document used
> in the third release on 8 May. We are grateful for your dedication to
> the group.
>
Please join our meeting at 1.00 PM UTC Wednesday 13 May 2020 via this
link
https://global.gotomeeting.com/join/903049133 ; you’ll find the points
for discussion in the rolling agenda

.
We have prepared a copy of our current sub-group document

of the last release as a reference to check /complement the content of
the next one in the new structure and, for those who were able to attend
the webinar on May 12 (recording is available here
), the restructured
google document for our section (clinical) is here

and the pdf of the full document for a general overview is here
.
In addition here is the updated timeline

What has been done by the editorial team is to take the content of our
document (3^rd release) and propose its organisation according to the
new structure. This has to be reviewed by our sub-group. In addition the
restructured document contains a number of information at the top that
you re all encouraged to read.
Agenda points pasted in this mail for your convenience :  input and
discussion needed for each point.:
1. Updates on where we stand (3rd release) and new structure of the
document (Dawei).
2. Timeline and next steps (Anne)
3. Comments received for our previous document (Christian)
4. Zotero file of resources (Dawei/Young-Joo Lee
)
5. Nomination/volunteer for a) decision tree working group and b)
dealing with some editorial / style questions, such as, referencing
style, language choice, glossary contributions, etc.
6. New contributions for imaging, other?
7. Discuss the relevance of a use case from our sub-group
8. Reminder : send questions to Legal-ethical sub-group using the “pose
your question-document” here

Waiting forward to our meeting,
*Please join the meeting from your computer, tablet or smartphone. *
https://global.gotomeeting.com/join/903049133
*You can also dial in using your phone. *
United States: +1 (312) 757-3117
*Access Code: 903-049-133 *
*More phone numbers *
Australia: +61 2 8355 1038
Austria: +43 7 2081 5337
Belgium: +32 28 93 7002
Canada: +1 (647) 497-9373
Denmark: +45 32 72 03 69
Finland: +358 923 17 0556
France: +33 170 950 590
Germany: +49 892 0194 301
Ireland: +353 15 295 146
Italy: +39 0 291 29 46 27
Netherlands: +31 202 251 001
New Zealand: +64 9 913 2226
Norway: +47 21 93 37 37
Spain: +34 932 75 1230
Sweden: +46 853 527 818
Switzerland: +41 225 4599 60
United Kingdom: +44 808 178 0872
New to GoToMeeting? Get the app now and be ready when your first meeting
starts:
https://global.gotomeeting.com/install/903049133
--
--
Dr Anne Cambon-Thomsen
Directrice de recherche émérite au CNRS
UMR 1027, Inserm, Univ Toulouse III - Paul Sabatier www.u1027.inserm.fr

Plateforme sociétale genotoul http://societal.genotoul.fr/
Ambassador of the Research Data Alliance (RDA) for health sciences and
research ethics www.rd-alliance.org
37 allées Jules Guesde     F-31000 Toulouse
Tel : +33 (0)5 61 14 59 59 Mobile: +33 (0)6 79 41 13 48    Fax : +33
(0)5 61 14 56 23   Skype: act_pro
E-mail : <***@***.***-tlse3.fr>
--
Dr Anne Cambon-Thomsen
Directrice de recherche émérite au CNRS
UMR 1027, Inserm, Univ Toulouse III - Paul Sabatier www.u1027.inserm.fr

Plateforme sociétale genotoul http://societal.genotoul.fr/
Ambassador of the Research Data Alliance (RDA) for health sciences and
research ethics www.rd-alliance.org
37 allées Jules Guesde  F-31000 Toulouse
Tel : +33 (0)5 61 14 59 59 Mobile: +33 (0)6 79 41 13 48    Fax : +33
(0)5 61 14 56 23   Skype: act_pro
E-mail : <***@***.***-tlse3.fr>